A new study led by a researcher at University College London (UCL) has found that the anti-obesity medication semaglutide (Ozempic and Wegovy) may help prevent heart attacks and other major cardiovascular events, regardless of how much weight a…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply